GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Additional Paid-In Capital

Abbisko Cayman (STU:8ZD) Additional Paid-In Capital : €705.45 Mil(As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Additional Paid-In Capital?


Abbisko Cayman's quarterly additional paid-in capital declined from Dec. 2022 (€744.51 Mil) to Jun. 2023 (€708.67 Mil) but then stayed the same from Jun. 2023 (€708.67 Mil) to Dec. 2023 (€705.45 Mil).

Abbisko Cayman's annual additional paid-in capital declined from Dec. 2021 (€746.09 Mil) to Dec. 2022 (€744.51 Mil) and declined from Dec. 2022 (€744.51 Mil) to Dec. 2023 (€705.45 Mil).


Abbisko Cayman Additional Paid-In Capital Historical Data

The historical data trend for Abbisko Cayman's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Additional Paid-In Capital Chart

Abbisko Cayman Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
- - 746.09 744.51 705.45

Abbisko Cayman Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial 746.09 - 744.51 708.67 705.45

Abbisko Cayman Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Abbisko Cayman Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbisko Cayman (STU:8ZD) Business Description

Traded in Other Exchanges
Address
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (STU:8ZD) Headlines

No Headlines